Back to Search Start Over

Determinants of Urogenital Schistosomiasis Among Pregnant Women and its Association With Pregnancy Outcomes, Neonatal Deaths, and Child Growth.

Authors :
Murenjekwa, Wellington
Makasi, Rachel
Ntozini, Robert
Chasekwa, Bernard
Mutasa, Kuda
Moulton, Lawrence H
Tielsch, James M
Humphrey, Jean H
Smith, Laura E
Prendergast, Andrew J
Bourke, Claire D
SHINE Trial Team
Source :
Journal of Infectious Diseases; 4/15/2021, Vol. 223 Issue 8, p1433-1444, 12p
Publication Year :
2021

Abstract

<bold>Background: </bold>Schistosoma haematobium is a parasitic helminth that causes urogenital pathology. The impact of urogenital schistosomiasis during pregnancy on birth outcomes and child growth is poorly understood.<bold>Methods: </bold>Risk factors for urogenital schistosomiasis were characterized among 4437 pregnant women enrolled in a cluster-randomized community-based trial in rural Zimbabwe. Infection was defined via urine microscopy (≥1 S. haematobium egg) and urinalysis (hematuria). Associations between infection and pregnancy outcomes were assessed in case-control analyses using conditional logistic regression. The association of maternal infection with birthweight and length-for-age Z scores (LAZ) at 1 and 18 months of age were assessed using generalized estimating equations.<bold>Results: </bold>Urogenital schistosomiasis (egg positive and/or hematuria positive) was detected in 26.8% of pregnant women. Risk factors significantly associated with infection were maternal age, education, marital status, and religion; household drinking water source and latrine; study region; and season. Urogenital schistosomiasis was not significantly associated with adverse pregnancy outcomes (miscarriage, stillbirth, preterm, and small-for-gestational age), birthweight, neonatal death, or LAZ.<bold>Conclusions: </bold>Including pregnant women in antihelminthic treatment programs would benefit a large number of women in rural Zimbabwe. However, clearance of the low-intensity infections that predominate in this context is unlikely to have additive benefits for pregnancy outcomes or child growth.<bold>Clinical Trials Registration: </bold>NCT01824940. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00221899
Volume :
223
Issue :
8
Database :
Complementary Index
Journal :
Journal of Infectious Diseases
Publication Type :
Academic Journal
Accession number :
149991201
Full Text :
https://doi.org/10.1093/infdis/jiz664